Novo Nordisk Exonerated: Federal Jury Clears Fraud Allegations in Hemophilia Drug Promotion
November 10, 2025
In a significant legal development, a federal jury has acquitted Novo Nordisk
- May 23, 2026
Digital therapeutics, apps, and health technology
In a significant legal development, a federal jury has acquitted Novo Nordisk
Cogent Biosciences is making waves in the biopharmaceutical industry following the remarkable
As the field of biopharma continues to innovate and advance, Roche has
The recent acquisition of Metsera by Pfizer is a significant milestone in
In an era where heart disease remains a leading cause of mortality
On January 1, 2026, the Centers for Medicare & Medicaid Services (CMS)
The landscape of drug pricing in the United States is at a
In a groundbreaking clinical trial conducted in China, the innovative drug ivonescimab
In an ambitious move to tackle the soaring costs of prescription drugs,
In a landmark agreement, Novo Nordisk and Eli Lilly have significantly reduced
Eisai, a leading pharmaceutical company, is preparing to submit a significant application
In recent weeks, the landscape of the obesity treatment market has experienced
In a significant ruling that reverberates through the pharmaceutical industry, a Delaware
Supernus Pharmaceuticals has recently hit the brakes on new deliveries of its
The recent rejection of Vyglxia by the FDA has thrown Biohaven Pharmaceuticals
In an unexpected turn of events, biotechnology company UniQure has faced a
In a surprising turn of events, George Tidmarsh, the former Director of
In a surprising turn of events, UniQure, a prominent player in the
In the ever-evolving landscape of pharmaceutical developments, the ongoing legal dispute between
Eli Lilly, a leading global pharmaceutical company, has recently announced a groundbreaking
